Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPO | P05164 | 19/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.54 |
| ▸ | TPO | P07202 | 18/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28896597 | 1.00 | MPO (0.54) | MPOOPRM1TPOCYP3A4KCNH2 | |
| SCHEMBL28896622 | 0.85 | MPO (0.49) | MPOOPRM1TPOCYP3A4KCNH2 | |
| SCHEMBL28896585 | 0.81 | MPO (0.58) | MPOOPRM1TPOCYP3A4KCNH2 | |
| SCHEMBL28896583 | 0.81 | MPO (0.58) | MPOOPRM1TPOCYP3A4KCNH2 | |
| SCHEMBL28896715 | 0.77 | MPO (0.56) | MPOOPRM1TPOCYP3A4KCNH2 | |
| SCHEMBL28896590 | 0.77 | MPO (0.56) | MPOOPRM1TPOCYP3A4KCNH2 | |
| SCHEMBL28896714 | 0.77 | MPO (0.56) | MPOOPRM1TPOCYP3A4KCNH2 | |
| SCHEMBL28896592 | 0.77 | MPO (0.56) | MPOOPRM1TPOCYP3A4KCNH2 | |
| SCHEMBL28896563 | 0.76 | MPO (0.45) | MPOOPRM1TPOCYP3A4KCNH2 | |
| SCHEMBL28896471 | 0.74 | MPO (0.53) | MPOOPRM1TPOCYP3A4KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115403584-B | 2-thio-2, 3-dihydropyrimidine-4-one derivatives, pharmaceutical compositions, preparation methods and applications thereof | 长春金赛药业有限责任公司 | 2024-04-02 | — | — | CN | disclosed |
| CN-115403584-A | 2-thio-2, 3-dihydropyrimidine-4-one derivative, pharmaceutical composition, preparation method and application thereof | 长春金赛药业有限责任公司 | 2022-11-29 | — | — | CN | disclosed |